Analysts' Actions: CSCO, COP, GOOG, FDX


Adobe Systems ( ADBE) downgraded at JMP from Market Perform to Underperform, JMP Securities said. $26 price target. Company cut its sales outlook and has exposure to Europe.

Acme Packet ( APKT) downgraded at Jefferies to Hold from Buy, Jefferies said. $21 price target. Hesitation by carriers to invest in wireline.

Beam ( BEAM) upgraded at Argus from Hold to Buy, Argus said. $74 price target. Company could be a possible takeover target.

Choice Hotels ( CHH) upgraded at Baird from Underperform to Neutral, Robert Baird said. $38 price target. Company is returning cash to shareholders and shorts may soon be scrambling to cover.

Colony Bankcorp ( CBAN) upgraded to hold at TheStreet Ratings.

Rockwell Collins ( COL) downgraded at Goldman to Sell, Goldman Sachs said. Company is facing increased competition and has high exposure to the defense sector. $46 price target.

ConocoPhillips ( COP) downgraded at Goldman from Neutral to Sell, Goldman Sachs said. Valuation call, based on a $58 price target.

Cisco ( CSCO) upgraded at BMO from Market Perform to Outperform, BMO Capital said. $21 price target. Solid, growing cash flow deserves a higher multiple.

Citrix Systems ( CTXS) rated new Hold at ThinkEquity. $84 price target. Company faces growth risks in Europe.

Coventry Health ( CVH) downgraded at Leerink to Market Perform, Leerink Swann said. Risk/reward is less favorable, ahead of the Supreme Court decision on healthcare reform.

Community Health ( CYH) rated new Buy at UBS. $36 price target. Leader in non urban hospital market with a growth track record.

Huntington Bancshares ( HBAN) rated new Neutral at JP Morgan. Company still lags in several key metrics. $7 price target.

HCA Holdings ( HCA) rated new Buy at UBS. $34 price target. Nation's largest healthcare provider focused on fast growing markets.

Huntington Ingalls ( HII) upgraded at Goldman from Sell to Neutral, Goldman Sachs said. $39 price target. Navy demand should remain strong, relative to other areas of defense.

Health Management ( HMA) rated new Buy at UBS. $11 price target. Leading hospital operator in fast growing southeast non-urban market.

HSN ( HSNI) downgraded at Citigroup to Neutral from Buy, Citigroup said. $42.50 price target. Strong recent performance in shares.

LinkedIn ( LNKD) initiated as a sell at TheStreet Ratings.

If you liked this article you might like

Buying Adobe Systems With a Bounce in Mind

U.S. Indices Close Mixed as Fed Readies to Reduce Balance Sheet

Dow, S&P 500 Set New Records as Fed Moves to Unwind Balance Sheet

Cramer: Dominoes Are in Play Today

Stocks In Negative Territory as Chances for December Hike Surge